James Whittle

Title: **James Whittle: Innovator in Influenza Research**

Introduction

James Whittle is an accomplished inventor based in Boston, MA. He is recognized for his significant contributions to the field of influenza research, particularly through the development of a novel antibody that can effectively combat influenza infections.

Latest Patents

Whittle holds a patent for a "Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin." This innovative invention features an antibody that specifically binds to influenza hemagglutinin, inhibiting its ability to attach to sialic acid. The patent also encompasses methods, compositions, and kits that utilize this groundbreaking antibody for preventing or treating influenza infections.

Career Highlights

James Whittle's career has spanned influential organizations, including Duke University and the Children's Medical Center Corporation. His work has significantly advanced the understanding of how antibodies can interact with virus proteins to provide more effective treatments for influenza.

Collaborations

Throughout his career, Whittle has collaborated with notable peers, including Stephen C. Harrison and Barton F. Haynes. These collaborations have helped foster innovation and research in the field of virology, leading to new insights and therapeutic approaches.

Conclusion

James Whittle's patent for a broadly neutralizing influenza antibody represents a pivotal innovation in the fight against viral infections. His dedication to research and collaboration with other experts in the field continues to impact public health positively. As influenza remains a global health concern, the contributions of inventors like Whittle are invaluable in developing effective preventive and therapeutic measures.